Vaccines - United Kingdom

Global Research & Data Services
April 18, 2011
SKU: GRDS6631232
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020
7/14/2014 | published by: GlobalData
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020 Summary Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to  |  read more...
USD 5,995
PHARMACEUTICAL MARKET INDIA 2014-2020 : Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines
8/1/2014 | published by: Kelly Scientific Publications
PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines “PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing  |  read more...
USD 2,000
Cancer Vaccines Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Cancer Vaccines Drug Pipeline Update 2014 Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has proved elusive, leaving  |  read more...
USD 6,746
China Animal Vaccine Industry Report, 2013-2016
7/1/2014 | published by: Research in China
China Animal Vaccine Industry Report, 2013-2016 China Animal Vaccine Industry Report, 2013-2016 by ResearchInChina covers the followings: The market size, market structure and competitive landscape of the global animal vaccine industry;  |  read more...
USD 2,500
Vaccine Partnering Terms and Agreements
7/1/2014 | published by: Current Partnering
Vaccine Partnering Terms and Agreements The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare  |  read more...
USD 2,995
Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2
7/1/2014 | published by: MarketsandMarkets
Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2018  |  read more...
USD 4,650
Cancer Vaccine Partnering Terms and Agreements
5/1/2014 | published by: Current Partnering
Cancer Vaccine Partnering Terms and Agreements The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.  |  read more...
USD 1,995
Infectious Vaccines Partnering Terms and Agreements
6/1/2014 | published by: Current Partnering
Infectious Vaccines Partnering Terms and Agreements Report scope Infectious Vaccines Partnering Agreements is intended to provide the reader with an in-depth understanding and access to infectious vaccines trends and structure of deals entered  |  read more...
USD 1,995
Update: Vaccines Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
Vaccines Pipeline Highlights – 2014 Update The latest report Vaccines Pipeline Highlights – 2014 Update, provides most up-to-date information on key pipeline molecules in the global Vaccines market. It covers emerging therapies for Vaccines in active  |  read more...
USD 840
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany
6/1/2014 | published by: GBI Research
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary  |  read more...
USD 3,500
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 654  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!